China Energy Storage Technology Development Limited — Capital/Financing Update 2021

Oct 31, 2021

To be valid, the whole of this Provisional Allotment Letter must be returned. 本暫定配額通知書必須整份交回，方為有效。

IMPORTANT 重要提示

Reference is made to the prospectus issued by Link-Asia International MedTech Group Limited (the “ Company ”) dated 1 November 2021 in relation to the Rights Issue (the “ Prospectus ”). The PAL and EAF should be read in conjunction with the Prospectus. Capitalised terms used herein shall have the same meanings as those defined in the Prospectus unless the context requires otherwise.

茲提述環亞國際醫療科技集團有限公司（「 本公司 」）就供股刊發日期為二零二一年十一月一日之供股章程（「 供 股章程 」）。暫定配額通知書及額外申請表格應與供股章程一併閱覽。除文義另有所指外，本暫定配額通知 書所用詞彙與供股章程所界定者具有相同涵義。

THIS PROVISIONAL ALLOTMENT LETTER (“ PAL ”) IS VALUABLE AND TRANSFERABLE AND REQUIRES YOUR IMMEDIATE ATTENTION. THE OFFER CONTAINED IN THIS PAL AND THE ACCOMPANYING FORM OF APPLICATION FOR EXCESS RIGHTS SHARES (“ EAF ”) WILL EXPIRE AT 4:00 P.M. ON MONDAY, 15 NOVEMBER 2021 (OR SUCH LATER DATE AND/OR TIME AS MENTIONED IN THE PARAGRAPH HEADED “ EFFECT OF BAD WEATHER OR EXTREME CONDITIONS ON THE LATEST TIME FOR ACCEPTANCE OF AND PAYMENT FOR THE RIGHTS SHARES AND APPLICATION FOR AND PAYMENT FOR EXCESS RIGHTS SHARES ” IN THE ENCLOSED SHEET).

本暫定配額通知書（「 暫定配額通知書 」）乃具有價值及可轉讓，務請即時處理。本暫定配額通知書所載之要 約及隨附之額外供股股份申請表格（「 額外申請表格 」）將於二零二一年十一月十五日（星期一）下午四時正（或 根據附頁「 惡劣天氣或極端情況對接納供股股份並繳付股款以及申請額外供股股份並繳付股款之最後時限 之影響 」一段所述之較後日期及╱或時間）截止。

IF YOU ARE IN ANY DOUBT AS TO ANY ASPECT OF THIS PAL OR AS TO THE ACTION TO BE TAKEN, YOU SHOULD CONSULT YOUR STOCKBROKER, LICENSED DEALER IN SECURITIES OR REGISTERED INSTITUTION IN SECURITIES, BANK MANAGER, SOLICITOR, PROFESSIONAL ACCOUNTANT OR OTHER PROFESSIONAL ADVISERS.

閣下如對本暫定配額通知書任何方面或應採取之行動有任何疑問，應諮詢 閣下之股票經紀、持牌證券交 易商或註冊證券機構、銀行經理、律師、專業會計師或其他專業顧問。

A copy of this PAL, together with a copy of the Prospectus, the EAF and other documents specified in the paragraph headed “13. DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES” in Appendix III to the Prospectus, have been registered with the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). The Registrar of Companies in Hong Kong, the Stock Exchange and the Securities and Futures Commission of Hong Kong take no responsibility as to the contents of any of these documents.

本暫定配額通知書之文本連同供股章程、額外申請表格及於供股章程附錄三「13.送呈公司註冊處處長之文件」 一段所述其他文件之文本，已按香港法例第 32 章公司（清盤及雜項條文）條例第 342C 條之規定送呈香港公司 註冊處處長進行登記。香港公司註冊處處長、聯交所及香港證券及期貨事務監察委員會對任何該等文件之 內容概不負責。

Hong Kong Exchanges and Clearing Limited, the Stock Exchange and HKSCC take no responsibility for the contents of this PAL, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this PAL.

香港交易及結算所有限公司、聯交所及香港結算對本暫定配額通知書之內容概不負責，對其準確性或完整 性亦不發表任何聲明，並明確表示概不就因本暫定配額通知書全部或任何部分內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。

Dealings in the Shares and the Rights Shares in both their nil-paid form and fully-paid form may be settled through CCASS and you should consult your stockbroker, licensed dealer in securities or registered institution in securities, bank manager, solicitor, professional accountant or other professional advisers for details of these settlement arrangements and how such arrangements may affect your rights and interests.

股份及供股股份（以未繳股款及繳足股款形式）之買賣可透過中央結算系統交收，務請諮詢 閣下之股票經 紀、持牌證券交易商或註冊證券機構、銀行經理、律師、專業會計師或其他專業顧問，以了解有關交收安排 及該等安排對 閣下權利及權益之影響之詳情。

–PAL-1–

Subject to the granting of the listing of, and the permission to deal in, the Rights Shares (in both their nil-paid and fully-paid forms) on the Stock Exchange as well as compliance with the stock admission requirements of HKSCC, the Rights Shares (in both their nil-paid and fully-paid forms) will be accepted as eligible securities by HKSCC for deposit, clearance and settlement in CCASS with effect from the respective commencement dates of dealings in the Rights Shares (in both their nil-paid and fully-paid forms) on the Stock Exchange, or such other dates as determined by HKSCC. Settlement of transactions between participants of the Stock Exchange on any trading day is required to take place in CCASS on the second trading day thereafter. All activities under CCASS are subject to the General Rules of CCASS and CCASS Operational Procedures in effect from time to time.

待供股股份（以未繳股款及繳足股款形式）獲批准於聯交所上市及買賣以及遵守香港結算之股份接納規定後， 供股股份（以未繳股款及繳足股款形式）將獲香港結算接納為合資格證券，可自該等供股股份（以未繳股款及 繳足股款形式）各自於聯交所開始買賣日期或香港結算釐定之有關其他日期起於中央結算系統內寄存、結 算及交收。聯交所參與者之間於任何交易日進行之交易須於其後第二個交易日在中央結算系統內進行交收。 在中央結算系統進行之一切活動均須依據不時生效之中央結算系統一般規則及中央結算系統運作程序規 則進行。

All times and dates stated in this PAL refer to Hong Kong local times and dates. 本暫定配額通知書所述所有時間及日期均指香港本地時間及日期。

In case of any inconsistency between the English and Chinese versions of this PAL, the English version will prevail. 倘本暫定配額通知書之中英文版本有任何歧義，概以英文版本為準。

This PAL and all applications pursuant to it shall be governed by and construed in accordance with the laws of Hong Kong. 本暫定配額通知書及據此作出的所有申請均須受香港法例規管及按其詮釋。

TO ACCEPT THE PROVISIONAL ALLOTMENT OF THE RIGHTS SHARES AS SPECIFIED IN THIS PAL IN FULL, YOU MUST LODGE THIS PAL INTACT WITH THE REGISTRAR, TRICOR INVESTOR SERVICES LIMITED, AT LEVEL 54, HOPEWELL CENTRE, 183 QUEEN’S ROAD EAST, HONG KONG TOGETHER WITH A REMITTANCE, BY CHEQUE OR BANKER’S CASHIER ORDER, IN HONG KONG DOLLARS FOR THE FULL AMOUNT SHOWN IN BOX C OF FORM A SO AS TO BE RECEIVED BY THE REGISTRAR NO LATER THAN 4:00 P.M. ON MONDAY, 15 NOVEMBER 2021 (OR, UNDER BAD WEATHER CONDITIONS AND/OR EXTREME CONDITIONS, SUCH LATER TIME OR DATE AS MENTIONED IN THE PARAGRAPH HEADED “ EFFECT OF BAD WEATHER OR EXTREME CONDITIONS ON THE LATEST TIME FOR ACCEPTANCE OF AND PAYMENT FOR THE RIGHTS SHARES AND APPLICATION FOR AND PAYMENT FOR EXCESS RIGHTS SHARES ” IN THE ENCLOSED SHEET). ALL REMITTANCES MUST BE MADE IN HONG KONG DOLLARS BY CHEQUES WHICH MUST BE DRAWN ON AN ACCOUNT WITH, OR BANKER’S CASHIER ORDERS WHICH MUST BE ISSUED BY, A LICENSED BANK IN HONG KONG AND MADE PAYABLE TO “ LINK-ASIA INTERNATIONAL MEDTECH GROUP LIMITED — PAL ACCOUNT ” AND CROSSED “ Account Payee Only ”.

閣下如欲全數接納本暫定配額通知書所述供股股份的暫定配額，須不遲於二零二一年十一月十五日（星期 一）下午四時正（或於惡劣天氣及╱或極端情況下根據附頁「 惡劣天氣或極端情況對接納供股股份並繳付股 款以及申請額外供股股份並繳付股款之最後時限之影響 」一段所述之有關較後時間或日期）將本暫定配額 通知書整份連同表格甲之丙欄所示的港元全數股款的支票或銀行本票送達過戶處卓佳證券登記有限公司 （地址為香港皇后大道東 183 號合和中心 54 樓）。所有股款須以港元繳付，並以香港持牌銀行賬戶開出的支票 或香港持牌銀行發出的銀行本票支付，以「 LINK-ASIA INTERNATIONAL MEDTECH GROUP LIMITED[—] PAL ACCOUNT 」為收款人，並以「 只准入抬頭人賬戶 」劃線方式開出。

INSTRUCTIONS ON TRANSFER AND SPLITTING ARE ALSO SET OUT IN THE ENCLOSED SHEET. 有關轉讓及分拆的指示載於附頁。

NO RECEIPT WILL BE GIVEN FOR SUCH REMITTANCE. 本公司將不會就有關股款發出收據。

Each person accepting the provisional allotment specified in this PAL confirms that he/she/it has read the terms and conditions and acceptance procedures set out in the enclosed sheet and in the Prospectus and agrees to be bound by them.

接納本暫定配額通知書所載暫定配額的每位人士均確認其已閱讀附頁及供股章程所載條款及條件以及接 納手續，並同意受其約束。

–PAL-2–

Form A 表格甲

Hong Kong branch share registrar and transfer office: Tricor Investor Services Limited Level 54, Hopewell Centre 183 Queen’s Road East Hong Kong

香港股份過戶登記分處： 卓佳證券登記有限公司 香港 皇后大道東 183 號 合和中心 54 樓

Link-Asia International MedTech Group Limited 環亞國際醫療科技集團有限公司

(incorporated in the Cayman Islands with limited liability)

（於開曼群島註冊成立的有限公司）

(Stock code: 1143) （股份代號：1143）

RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY TWO (2) EXISTING SHARES HELD ON THE RECORD DATE AT THE SUBSCRIPTION PRICE OF HK$0.20 PER RIGHTS SHARE PAYABLE IN FULL ON ACCEPTANCE BY NO LATER THAN 4:00 P.M. ON MONDAY, 15 NOVEMBER 2021 按於記錄日期每持有兩 (2) 股現有股份 可獲發一 (1) 股供股股份之基準 以每股供股股份 0.20 港元之認購價 進行供股 股款須不遲於二零二一年十一月十五日（星期一） 下午四時正接納時繳足

Registered office: 註冊辦事處： Clifton House 75 Fort Street PO Box 1350 Grand Cayman KY1-1108 Cayman Islands

Principal place of business in Hong Kong: Suites 3501 & 3513–14 35th Floor, Tower 6 The Gateway, Harbour City Tsim Sha Tsui, Kowloon Hong Kong 香港主要營業地點： 香港 九龍尖沙咀 海港城港威大廈 第 6 座 35 樓 3501 及 3513–14 室 1 November 2021 二零二一年十一月一日

PROVISIONAL ALLOTMENT LETTER 暫定配額通知書

Name(s) and address of the Qualifying Shareholder(s) 合資格股東姓名及地址

Provisional Allotment Letter No. 暫定配額通知書編號

Total number of Shares registered in your name(s) on Friday, 29 October 2021 於二零二一年十月二十九日（星期五）以 閣下名 義登記之股份總數 Box A 甲欄

Number of Rights Shares provisionally allotted to you subject to payment in full on acceptance by no later than 4:00 p.m. on Monday, 15 November 2021 暫定配發予 閣下之供股股份數目，惟須不遲於 二零二一年十一月十五日（星期一）下午四時正接 納時全數繳足股款方可作實 Box B 乙欄 Total subscription monies payable on acceptance in full 接納時應全數繳足之認購股款總額 Box C HK$ 丙欄 港元

Name of bank on which cheque/banker’s cashier order is drawn: 支票╱銀行本票之付款銀行名稱：

Cheque/banker’s cashier order number: 支票╱銀行本票號碼：

Please insert your contact telephone number here: 請在此填上 閣下之聯絡電話號碼：

–PAL-3–

A SEPARATE CHEQUE OR BANKER’S CASHIER ORDER MUST ACCOMPANY EACH APPLICATION NO RECEIPT WILL BE GIVEN FOR REMITTANCE 每份申請表格須隨附一張獨立開出之支票或銀行本票 本公司將不會發出股款收據

–PAL-4–

IN THE EVENT OF TRANSFER OF RIGHTS TO SUBSCRIBE FOR RIGHTS SHARE(S), HONG KONG AD VALOREM STAMP DUTY IS PAYABLE ON EACH SALE AND EACH PURCHASE. A GIFT OR TRANSFER OF BENEFICIAL INTEREST OTHER THAN BY WAY OF SALE IS ALSO LIABLE TO HONG KONG AD VALOREM STAMP DUTY. EVIDENCE OF PAYMENT OF HONG KONG AD VALOREM STAMP DUTY WILL BE REQUIRED BEFORE REGISTRATION OF ANY TRANSFER OF THE RIGHTS TO SUBSCRIBE FOR THE RIGHTS SHARE(S) REPRESENTED BY THIS DOCUMENT.

於轉讓認購供股股份之權利時，每宗買賣均須繳付香港從價印花稅。實益權益之饋贈或轉讓（而非出售）亦 須繳付香港從價印花稅。於登記轉讓本文件所述任何轉讓認購供股股份之權利前，須出示已繳付從價印花 稅之證明。

Form B Form B FORM OF TRANSFER AND NOMINATION 表格乙 轉讓及提名表格乙

(To be completed and signed only by the Qualifying Shareholder(s) who wish(es)

to transfer all of his/her/its/their right(s) to subscribe for the Rights Shares comprised herein) （僅供擬悉數轉讓其╱彼等於本暫定配額通知書所列供股股份認購權之合資格股東填寫及簽署）

• To: The Directors,

Link-Asia International MedTech Group Limited

致： 環亞國際醫療科技集團有限公司

列位董事

Dear Sirs and Madams, 敬啟者：

I/We hereby transfer all of my/our rights to subscribe for the Rights Shares comprised in this PAL to the person(s) accepting the same and signing the registration application form (Form C) below.

本人╱吾等謹將本暫定配額通知書所述本人╱吾等之供股股份認購權悉數轉讓予接受此權利並簽署以下登 記申請表格（表格丙）之人士。

Signature(s) of the Qualifying Shareholder(s) (all joint Shareholders must sign) 合資格股東簽署（所有聯名合資格股東均須簽署）

Date: 2021 日期：二零二一年 月 日

Hong Kong stamp duty of HK$5.00 and ad valorem stamp duty is payable in connection with the transfer of rights to subscribe for the Rights Shares. 轉讓認購供股股份之權利須繳付 5.00 港元之香港印花稅及從價印花稅。

–PAL-5–

Form C 表格丙

REGISTRATION APPLICATION FORM 登記申請表格

(To be completed and signed only by the person(s) to whom the rights to subscribe

for the Rights Shares have been transferred) （僅供承讓供股股份認購權之人士填寫及簽署）

To: The Directors,

Link-Asia International MedTech Group Limited

致： 環亞國際醫療科技集團有限公司

列位董事

Dear Sirs and Madams,

敬啟者：

I/We request you to register the number of Rights Shares mentioned in Box B of Form A in my/our name(s). I/We agree to accept the same on the terms embodied in this PAL and the Prospectus and subject to the memorandum and articles of association of the Company.

本人╱吾等謹請 閣下將表格甲之乙欄所列的供股股份數目登記於本人╱吾等名下。本人╱吾等同意按照 本暫定配額通知書及供股章程所載條款，以及在本公司的組織章程大綱及細則規限下，接納此等供股股份。

==> picture [44 x 44] intentionally omitted <==

Existing Shareholder(s) Please mark “X” in this box 現有股東 請在本欄內填上「X」號

		份數目登記於本人╱吾等名下。本人╱吾等同意按照 司的組織章程大綱及細則規限下，接納此等供股股份。	份數目登記於本人╱吾等名下。本人╱吾等同意按照 司的組織章程大綱及細則規限下，接納此等供股股份。
		Existing Shareholder(s) Please mark “X” in this box 現有股東 請在本欄內填上「X」號
To be completed inBLOCKletters inENGLISH. Joint applicants should give the address of the first-named applicant only. For Chinese applicant(s), please provide your name in both English and Chinese. 請用英文正楷填寫。聯名申請人僅需填寫排名首位申請人之地址。 中國籍申請人請填寫中英文姓名。
Name in English 英文姓名	Family name/Company name 姓氏╱公司名稱	Other name(s) 名字	Name in Chinese 中文姓名
Names of joint applicant(s) in English (if applicable) 聯名申請人英文姓名（如適用）
Address in English (joint applicants should give the address of the first-named applicant only) 英文地址（聯名申請人僅需填寫排名首位申請人之地址）
Occupation 職業		Telephone number 電話號碼
Dividend instructions 股息指示
Name and address of bank 銀行名稱及地址		Bank account number 銀行賬戶號碼

Address in English (joint applicants should give the address of the first-named applicant only)	Address in English (joint applicants should give the address of the first-named applicant only)	Address in English (joint applicants should give the address of the first-named applicant only)
英文地址（聯名申請人僅需填寫排名首位申請人之地址）
Occupation		Telephone number
職業		電話號碼
	Dividend instructions
	股息指示
Name and address of bank		Bank account number
銀行名稱及地址		銀行賬戶號碼

Signature(s) of applicant(s) (all joint applicants must sign) 申請人簽署（所有聯名申請人均須簽署）

Date: 2021 日期：二零二一年 月 日

Hong Kong ad valorem stamp duty is payable in connection with the acceptance of rights to subscribe for the Rights Shares. 接納認購供股股份之權利須繳付香港從價印花稅。

–PAL-6–

— This page is intentionally left blank —

— 此乃白頁 —

— This page is intentionally left blank —

— 此乃白頁 —

Link-Asia International MedTech Group Limited 環亞國際醫療科技集團有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock code: 1143)

1 November 2021

Dear Qualifying Shareholder(s),

INTRODUCTION

Reference is made to the prospectus of Link-Asia International MedTech Group Limited dated 1 November 2021 in relation to the Rights Issue (the “ Prospectus ”). Terms defined in the Prospectus shall have the same meanings when used herein unless the context otherwise requires. In accordance with the terms set out in the Prospectus, the Directors have provisionally allotted to you a number of Rights Shares on the basis of one (1) Rights Share for every two (2) existing Shares held and registered in your name(s) as at the Record Date (i.e. Friday, 29 October 2021) at a subscription price of HK$0.20 per Rights Share. Your holding of Shares as at the Record Date is set out in Box A in Form A and the number of Rights Shares provisionally allotted to you is set out in Box B in Form A.

The Rights Issue is only underwritten on a best effort basis. Pursuant to the Company’s constitutional documents and the Companies Act, there are no requirements for minimum levels of subscription in respect of the Rights Issue. Subject to fulfilment or satisfaction of the conditions precedent of the Rights Issue, the Rights Issue shall proceed regardless of its level of acceptances, and up to 325,773,210 Rights Shares are committed to be subscribed subject, however, to any Scaling-down vis-a-vis the MGO Obligation or the Public Float Requirement. In the event of under-subscription, any Rights Shares not taken up by the Qualifying Shareholders whether under PAL(s) or EAF(s), or transferees of nil-paid Rights Shares, and not subscribed by subscribers procured by the Underwriter will not be issued, and hence, the size of the Rights Issue will be reduced accordingly.

The Rights Shares, when allotted, issued and fully paid, shall rank pari passu in all respects with the Shares then in issue, including the right to receive all dividends and distributions which may be declared, made or paid with a record date which falls on or after the date of allotment of the Rights Shares in their fully-paid form.

Subject to the granting of the listing of, and the permission to deal in, the Rights Shares (in both their nil-paid and fully-paid forms) on the Stock Exchange as well as compliance with the stock admission requirements of HKSCC, the Rights Shares (in both their nil-paid and fully-paid forms) will be accepted as eligible securities by HKSCC for deposit, clearance and settlement in CCASS with effect from the respective commencement dates of dealings in the Rights Shares (in both their nil-paid and fully-paid forms) on the Stock Exchange, or such other dates as determined by HKSCC. Settlement of transactions between participants of the Stock Exchange on any trading day is required to take place in CCASS on the second trading day thereafter. All activities under CCASS are subject to the General Rules of CCASS and CCASS Operational Procedures in effect from time to time.

The Rights Issue is conditional upon, among others, the Underwriting Agreement having become unconditional and the Underwriter not having terminated the Underwriting Agreement in accordance with the terms thereof (a summary of which is set out in the section headed “Termination of the Underwriting Agreement” in the Prospectus). Accordingly, the Rights Issue may or may not proceed.

PROCEDURES FOR ACCEPTANCE AND PAYMENT

To take up your provisional allotment in full, you must lodge the whole of this PAL intact in accordance with the instructions printed herein intact with the Registrar, Tricor Investor Services Limited at Level 54, Hopewell Centre, 183 Queen’s Road East, Hong Kong together with a remittance in Hong Kong dollars for the full amount payable on acceptance, as set out in Box C in Form A by no later than 4:00 p.m. on Monday, 15 November 2021 (or, under bad weather conditions and/or extreme conditions, such later time or date as mentioned in the paragraph headed “ EFFECT OF BAD WEATHER OR EXTREME CONDITIONS ON THE LATEST TIME FOR ACCEPTANCE OF AND PAYMENT FOR THE RIGHTS SHARES AND APPLICATION FOR AND PAYMENT FOR EXCESS RIGHTS SHARES ” below). All remittances must be made in Hong Kong dollars by cheques which must be drawn on an account with, or by banker’s cashier orders which must be issued by, a licensed bank in Hong

–PAL-9–

Kong and made payable to “ LINK-ASIA INTERNATIONAL MEDTECH GROUP LIMITED — PAL ACCOUNT ” and crossed “ Account Payee Only ”. Such payment will constitute acceptance of the provisional allotment of the Rights Shares on the terms of this PAL and the Prospectus and subject to the memorandum and articles of association of the Company. No receipt will be given for such remittances. All enquiries in connection with this PAL should be addressed to the Registrar at the above address.

It should be noted that unless this PAL, together with the appropriate remittance for the amount shown in Box C in Form A, has been lodged with the Registrar for registration as described above by no later than 4:00 p.m. on Monday, 15 November 2021 (or, under bad weather conditions and/or extreme conditions, such later time or date as mentioned in the paragraph headed “ EFFECT OF BAD WEATHER OR EXTREME CONDITIONS ON THE LATEST TIME FOR ACCEPTANCE OF AND PAYMENT FOR THE RIGHTS SHARES AND APPLICATION FOR AND PAYMENT FOR EXCESS RIGHTS SHARES ” below) whether by the original allottee or any person to whom the provisional allotment has been validly transferred, the relevant provisional allotment and all rights and entitlements hereunder will be deemed to have been declined and will be cancelled and such Rights Shares will be available for application under the EAFs by the Qualifying Shareholders. The Company is not obliged to but may, at its sole absolute discretion, treat a PAL as valid and binding on the person(s) by whom or on whose behalf it is lodged even if the PAL is not completed in accordance with the relevant instructions. The Company may require such incomplete PAL to be completed by the relevant applicants at a later stage.

APPLICATION FOR EXCESS RIGHTS SHARES

The Qualifying Shareholders may apply, by way of excess application, for Rights Shares representing (i) any nil-paid Rights Shares provisionally allotted but not accepted by any of the Qualifying Shareholders or otherwise subscribed for by transferees of nil-paid Rights Shares prior to the Latest Time for Acceptance; (ii) subject to the provisions of the Underwriting Agreement, any entitlements of the Excluded Shareholders provisionally allotted to a nominee of the Company which are left unsold; (iii) any of the Rights Shares created from the aggregation of fractions of the Rights Shares; and (iv) the Scale-down PAL Shares (if any) and the Scale-down EAF Shares (if any).

Application for Excess Rights can be made only by duly completing and signing the EAF. The Company will, upon consultation with the Underwriter, allocate the Excess Rights Shares to the Qualifying Shareholders who apply for them on a pro rata basis by reference to the number of the Excess Rights Shares applied for. Reference will only be made to the number of Excess Rights Shares being applied for but no reference will be made to the Rights Shares comprised in applications by the PALs or the existing number of Shares held by Qualifying Shareholders. If the aggregate number of Rights Shares not taken up by the Qualifying Shareholders and/or transferees of nil-paid Rights Shares under the PALs is greater than the aggregate number of Excess Rights Shares applied for through the EAFs, the Company will allocate to each Qualifying Shareholder who applies for Excess Rights Shares in full application. No preference will be given to applications for topping up odd lots to whole board lots. It should be noted that the lodging of the EAF does not assure the Qualifying Shareholder of being allocated any Rights Shares in excess of those of his/her/its provisional allotments.

If a Qualifying Shareholder wishes to apply for any Rights Shares in addition to his/her/its provisional allotment, he/she/it must complete and sign an EAF enclosed with the Prospectus and lodge it together with a separate cheque or banker’s cashier order for the amount payable for the Excess Rights Shares being applied for with the Registrar by 4:00 p.m. on Monday, 15 November 2021 (or, under bad weather conditions and/or extreme conditions, such later time or date as mentioned in the paragraph headed “ EFFECT OF BAD WEATHER OR EXTREME CONDITIONS ON THE LATEST TIME FOR ACCEPTANCE OF AND PAYMENT FOR THE RIGHTS SHARES AND APPLICATION FOR AND PAYMENT FOR EXCESS RIGHTS

SHARES ” below). All remittances must be made in Hong Kong dollars by cheques which must be drawn on an account with, or banker’s cashier orders which must be issued by, a licensed bank in Hong Kong and made payable to “ LINK-ASIA INTERNATIONAL MEDTECH GROUP LIMITED — EAF ACCOUNT ” and crossed “Account Payee Only”. No receipt will be issued in respect of any remittance received.

SCALE-DOWN MECHANISMS

Pursuant to the Underwriting Agreement and the Appointment but subject to the Maximum Undertakings, as the Rights Issue is only underwritten by the Underwriter on a best effort basis, and so as to avoid the unwitting triggering of MGO Obligations and/or any non-compliance with Public Float Requirements, all applications for Rights Shares whether under the PAL(s) or the EAF(s), or by transferees of nil-paid Rights Shares, or by subscribers procured by the Underwriter will be made on the basis that the applications are to be scaled-down by the Company to a level which (a) does not trigger an MGO Obligation on the part of the applicant or parties acting in concert with him/her/it; and/or (b) does not result in the non-compliance of the Public Float Requirement on the part of the Company. Any subscription monies for the Scale-down PAL Shares or the Scale-down EAF Shares will be refunded to the applicants, and the Scale-down PAL Shares and the Scale-down EAF Shares will be made available for subscription by other Qualifying Shareholders through the EAF(s).

–PAL-10–

In addition, under and/or pursuant to the Scaling-down, any application for Rights Shares, whether under PAL(s) or EAF(s), shall be subject to the scale-down mechanisms of the Rights Issue as determined by the Company to levels which do not trigger any MGO Obligation or non-compliance of Public Float Requirement. Such scale-down of applications of Rights Shares shall operate on a fair and equitable basis under the following principles: (a) EAF(s) should be scaled down before PAL(s); and (b) where the scale-down is necessitated by the exceeding of shareholding by a group rather than an individual Shareholder, the allocations of EAF(s) and PAL(s) to members of the affected group should be made on a pro rata basis by reference to the number of Shares held by the affected applicants on the Record Date, but for the avoidance of any doubt, any or any such onward allocation(s) shall be subject to the Scaling-down as well.

TRANSFER

If you wish to transfer all of your rights to subscribe for the Rights Shares provisionally allotted to you hereunder, you must complete and sign the “Form of Transfer and Nomination” (Form B) and hand this PAL to the person(s) to or through whom you are transferring your rights. The transferee(s) must then complete and sign the “Registration Application Form” (Form C) and lodge this PAL intact together with a remittance for the full amount payable on acceptance as set out in Box C in Form A with the Registrar, Tricor Investor Services Limited at Level 54, Hopewell Centre, 183 Queen’s Road East, Hong Kong so as to be received by no later than 4:00 p.m. on Monday, 15 November 2021 (or, under bad weather conditions and/or extreme conditions, such later time or date as mentioned in the paragraph headed “ EFFECT OF BAD WEATHER OR EXTREME CONDITIONS ON THE LATEST TIME FOR ACCEPTANCE OF AND PAYMENT FOR THE RIGHTS SHARES AND APPLICATION FOR AND PAYMENT FOR EXCESS RIGHTS SHARES ” below).

SPLITTING

If you wish to accept only part of your provisional allotment or transfer part of your rights to subscribe for the Rights Shares provisionally allotted to you hereunder, or to transfer part or all of your rights to more than one person, the original PAL must be surrendered and lodged for cancellation by no later than 4:30 p.m. on Friday, 5 November 2021 to the Registrar, Tricor Investor Services Limited at Level 54, Hopewell Centre, 183 Queen’s Road East, Hong Kong, who will cancel the original PAL and issue new PALs in the denominations required which will be available for collection at the Registrar’s address set out above after 9:00 a.m. on the second Business Day after your surrender of the original PAL. It should be noted that Hong Kong ad valorem stamp duty is payable in connection with the transfer of your rights to subscribe for the relevant Rights Shares to the transferee(s) and the acceptance by the transferee(s) of such rights.

EFFECT OF BAD WEATHER OR EXTREME CONDITIONS ON THE LATEST TIME FOR ACCEPTANCE OF AND PAYMENT FOR THE RIGHTS SHARES AND APPLICATION FOR AND PAYMENT FOR EXCESS RIGHTS SHARES

Whenever any part of the expected timetable of the Rights Issue as enlisted in the provisions of the Underwriting Agreement may be interrupted by a typhoon, a black rainstorm warning or Extreme Conditions, the Company shall properly inform the Shareholders of the corresponding contingency arrangements, which contingency arrangements shall include the Latest Time for Acceptance not taking place on the time as scheduled:

• (a) if a tropical cyclone warning signal no. 8 or above, a black rainstorm warning and/or Extreme Conditions is in force in Hong Kong at any local time before 12:00 noon but no longer in force after 12:00 noon on the day on which the Latest Time for Acceptance is initially scheduled to fall, the Latest Time for Acceptance be extended to 5:00 p.m. on the same Business Day; or

• (b) if a tropical cyclone warning signal no. 8 or above, a black rainstorm warning and/or Extreme Conditions is in force in Hong Kong at any local time between 12:00 noon and 4:00 p.m. on the day on which the Latest Time for Acceptance is initially scheduled to fall, the Latest Time for Acceptance be extended to 4:00 p.m. on the following Business Day which does not have either of those warnings in force in Hong Kong at any time between 9:00 a.m. and 4:00 p.m.

If the Latest Time for Acceptance does not take place on or before 4:00 p.m. on Monday, 15 November 2021, the dates mentioned herein may be affected. The Company will notify the Shareholders by way of announcement(s) on any change to the expected timetable of the Rights Issue as soon as practicable.

–PAL-11–

FRACTIONAL ENTITLEMENTS

In any event, fractions of the Rights Shares will not be provisionally allotted to any of the Qualifying Shareholders and the Company will not accept applications for any fraction of Rights Shares. Fractional entitlements will be rounded down to the nearest whole number of Rights Shares. Any Rights Shares created from the aggregation of fractions of the Rights Shares will be made available for excess application by the Qualifying Shareholders as described in the paragraph headed “ Application for Excess Rights Shares ” above. Should there be no excess application by the Qualifying Shareholders, those Rights Shares created from the aggregation of fraction of the Rights Shares may or may not be taken up by the Underwriter.

WARNING OF THE RISKS OF DEALING IN SHARES AND NIL-PAID RIGHTS SHARES

It should be noted that the Shares have been dealt in on an ex-rights basis since Thursday, 21 October 2021. Dealings in the Rights Shares in the nil-paid form will take place from Wednesday, 3 November 2021 to Wednesday, 10 November 2021 (both days inclusive). If any of the conditions precedent of the Rights Issue is not fulfilled or waived (as applicable) or if the Underwriter terminate the Underwriting Agreement on or before 4:00 p.m. on Tuesday, 16 November 2021 (or such later time or date as may be agreed between the Company and the Underwriter in writing), the Rights Issue will not proceed.

Any Shareholder or other person dealing in the Shares and/or the nil-paid Rights Shares up to the date on which all the conditions precedent to which the Rights Issue are fulfilled or waived (as applicable) (and the date on which the Underwriter’s right of termination of the Underwriting Agreement ceases) will accordingly bear the risk that the Rights Issue may not become unconditional or may not proceed.

Shareholders and potential investors of the Company are advised to exercise caution when dealing in the Shares and/or the nil-paid Rights Shares. Any party (including the Shareholders and potential investors of the Company) who is in any doubt about his/her/its position or any action to be taken is recommended to consult his/her/its own professional adviser(s).

CHEQUES AND BANKER’S CASHIER ORDERS

All cheques or banker’s cashier orders will be presented for payment following receipt and all interest earned on such monies will be retained for the benefit of the Company. Without prejudice to the other rights of the Company in respect hereof, the Company reserves the right to reject any application for the Rights Shares in respect of which the accompanying cheque and/or banker’s cashier order is dishonoured on first presentation, and in that event the provisional allotment and all rights thereunder will be deemed to have been declined and will be cancelled. You must pay the exact amount payable upon application for the Rights Shares, and underpaid application will be rejected. Completion and return of this PAL together with a cheque or banker’s cashier order in payment for the Rights Shares, whether by a Qualifying Shareholder or by any nominated transferee, will constitute a warranty by you that the cheque or banker’s cashier order will be honoured on first presentation.

SHARE CERTIFICATES OF THE RIGHTS SHARES AND REFUND CHEQUES FOR THE RIGHTS ISSUE

Subject to fulfilment of the conditions precedent of the Rights Issue, share certificates for the fully-paid Rights Shares are expected to be posted on or before Tuesday, 23 November 2021 to those entitled thereto by ordinary post, at their own risk, to their registered addresses. If the Underwriting Agreement is terminated or not becoming unconditional, refund cheques will be posted on or before Tuesday, 23 November 2021 by ordinary post, at the respective Shareholders’ own risk, to their registered addresses. Refund cheques in respect of wholly or partially unsuccessful applications for Excess Rights Shares (if any) are expected to be posted on or before Tuesday, 23 November 2021, by ordinary post to the applicants, at their own risk, to their registered addresses. Each Shareholder will receive one share certificate for all allotted Shares.

TERMINATION OF THE UNDERWRITING AGREEMENT

If, prior to the Latest Time for Termination:

• (1) in the absolute opinion of the Underwriter, the success of the Rights Issue would be materially and adversely affected by:

• (a) the introduction of any new law or regulation or any change in existing law or regulation (or the judicial interpretation thereof) or other occurrence of any nature whatsoever which may in the absolute opinion of the Underwriter materially and adversely affects the business or the financial or trading position or prospects of the Group as a whole or is materially adverse in the context of the Rights Issue; or

–PAL-12–

• (b) the occurrence of any local, national or international event or change (whether or not forming part of a series of events or changes occurring or continuing before, and/or after the date hereof) of a political, military, financial, economic or other nature (whether or not ejusdem generis with any of the foregoing), or in the nature of any local, national or international outbreak or escalation of hostilities or armed conflict, or affecting local securities markets which may, in the absolute opinion of the Underwriter materially and adversely affects the business or the financial or trading position or prospects of the Group as a whole or materially and adversely prejudice the success of the Rights Issue or otherwise makes it inexpedient or inadvisable to proceed with the Rights Issue; or

• (2) any adverse change in market conditions (including without limitation, any change in fiscal or monetary policy, or foreign exchange or currency markets, suspension or material restriction on trading in securities) occurs which in the absolute opinion of the Underwriter is likely to materially or adversely affect the success of the Rights Issue or otherwise makes it inexpedient or inadvisable to proceed with the Rights Issue; or

• (3) there is any change in the circumstances of the Company or any member of the Group which in the absolute opinion of the Underwriter will adversely affect the prospects of the Company, including without limiting the generality of the foregoing the presentation of a petition or the passing of a resolution for the liquidation or winding up or similar event occurring in respect of any of member of the Group or the destruction of any material asset of the Group; or

• (4) any event of force majeure including, without limiting the generality thereof, any act of God, war, riot, public disorder, civil commotion or unrest, fire, flood, explosion, epidemic, pandemic, terrorism, strike or lock-out which would, in the absolute opinion of the Underwriter materially and adversely affects the business or the financial or trading position or prospects of the Group as a whole; or

• (5) in the absolute opinion of the Underwriter, there occurs any other material adverse change in relation to the business or the financial or trading position or prospects of the Group as a whole whether or not ejusdem generis with any of the foregoing; or

• (6) any matter which, had it arisen or been discovered immediately before the Prospectus Posting Date and not having been disclosed in the Prospectus Documents, would have constituted, in the absolute opinion of the Underwriter, a material omission in the context of the Rights Issue; or

• (7) any suspension in the trading of securities generally or the Company’s securities on the Stock Exchange for a period of more than twenty (20) consecutive trading days otherwise than due to or in connection with or in relation to the Underwriting Agreement and/or the Rights Issue and excluding any suspension in connection with the clearance of announcement or other matters in connection with the Underwriting Agreement and/or the Rights Issue; or

• (8) the Prospectus Documents when published contains information (either as to business prospects or the condition of the Group or as to its compliance with any laws or the Listing Rules or any applicable regulations) which has not prior to the date hereof been publicly announced or published by the Company and which may in the absolute opinion of the Underwriter be material to the Group as a whole upon completion of the Rights Issue and is likely to affect materially and adversely the success of the Rights Issue.

the Underwriter shall be entitled by a notice in writing to the Company, served prior to the Latest Time for Termination, to terminate the Underwriting Agreement.

If the Underwriter terminates the Underwriting Agreement, the Rights Issue will not proceed. A further announcement would be made by the Company if the Underwriting Agreement is terminated by the Underwriter.

DISTRIBUTION OF THIS PAL AND THE OTHER PROSPECTUS DOCUMENTS

The PAL shall only be sent to the Qualifying Shareholders. The Prospectus Documents will not be registered or filed under the applicable securities legislation of any jurisdiction other than Hong Kong. No action has been taken to permit the offering of the Rights Shares, or the distribution of the Prospectus Documents, in any territory other than Hong Kong.

Accordingly, no person receiving a copy of any of the Prospectus Documents in any territory outside Hong Kong may treat it as an offer or invitation to apply for the Rights Shares, unless in a territory such an offer or invitation could lawfully be made without compliance with any registration or other legal or regulatory requirements thereof.

–PAL-13–

It is the responsibility of the Qualifying Shareholders outside Hong Kong wishing to make an application for the Rights Shares to satisfy himself/herself/itself before acquiring any rights to subscribe for the Rights Shares as to the observance of the laws and regulations of all relevant territories, including the obtaining of any governmental or other consents, and to pay any taxes and duties required to be paid in such territory in connected therewith. Any acceptance of or application for Rights Shares by any person will be deemed to constitute a representation and warranty from such person to the Company that these local laws and requirements have been fully complied with. If you are in doubt as to your position, you should consult your own professional advisers. The Company reserves the right to refuse to accept any application for the Rights Shares where it believes that doing so would violate the applicable securities legislation or other laws or regulations of any jurisdiction. For the avoidance of doubt, neither HKSCC nor HKSCC Nominees Limited will give, or be subject to, any of the above representation and warranty.

GENERAL

Lodgment of this PAL with, where relevant, the “Form of Transfer and Nomination” (Form B) purporting to have been signed by the person(s) in whose favour this PAL has been issued shall be conclusive evidence of the title of the party or parties lodging it to deal with the same and to receive split letters of allotment and/or share certificates for the Rights Shares.

PERSONAL DATA COLLECTION — PAL

By completing, signing and submitting the forms accompanying this PAL, you agree to disclose to the Company, the Registrar and/ or their respective advisers and agents personal data and any information which they require about you or the person(s) for whose benefit you have made the acceptance of the provisional allotment of Rights Shares. The Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong) (the “ Ordinance ”) provides the holders of securities with rights to ascertain whether the Company or the Registrar holds their personal data, to obtain a copy of that data, and to correct any data that is inaccurate. In accordance with the Ordinance, the Company and the Registrar have the right to charge a reasonable fee for the processing of any data access request. All requests for access to data or correction of data or for information regarding policies and practices and the kinds of data held should be addressed to (i) the Company, at its principal place of business in Hong Kong at Suites 3501 & 3513–14, 35th Floor, Tower 6, The Gateway, Harbour City, Tsim Sha Tsui, Kowloon, Hong Kong or as notified from time to time in accordance with applicable law, for the attention of the company secretary of the Company; or (ii) (as the case may be) the Registrar at its address set out above for the attention of Privacy Compliance Officer.

Yours faithfully,For and on behalf of Link-Asia International MedTech Group Limited Lin Dailian Chairman and Executive Director

–PAL-14–

Link-Asia International MedTech Group Limited 環亞國際醫療科技集團有限公司

（於開曼群島註冊成立的有限公司）

（股份代號： 1143）

敬啟者：

緒言

茲提述環亞國際醫療科技集團有限公司就供股刊發日期為二零二一年十一月一日之供股章程（「 供股章程 」）。 除文義另有所指外，本暫定配額通知書所用詞彙與供股章程所界定者具有相同涵義。根據供股章程所載條款， 董事已按在記錄日期（即二零二一年十月二十九日（星期五））以 閣下名義登記及持有每兩 (2) 股現有股份可 獲發一 (1) 股供股股份之基準，按每股供股股份 0.20 港元之認購價向 閣下暫定配發供股股份。 閣下於記錄 日期持有之股份列於表格甲之甲欄，而 閣下獲暫定配發之供股股份數目列於表格甲之乙欄。

供股僅按竭誠基準獲包銷。根據本公司之公司組織章程文件及公司法，並無規定供股之最低認購水平。待 供股之先決條件獲達成或滿足後，不論其接納水平，供股將會繼續進行，且最多 325,773,210 股供股股份獲承 諾認購，惟須受強制性全面收購要約責任或公眾持股量規定的任何縮減所限。倘認購不足，本公司將不會 發行任何未獲合資格股東（不論根據暫定配額通知書或額外申請表格）或未繳股款供股股份的承讓人承購， 且未獲包銷商促成的認購人認購的供股股份，因此，供股的規模將相應縮減。

供股股份一經配發、發行及悉數繳足，將在各方面與當時已發行股份享有同等權利，包括收取於繳足股款 之供股股份配發日期或以後之記錄日期可能宣派、作出或派付之所有股息及分派之權利。

待供股股份（以未繳股款及繳足股款形式）獲批准於聯交所上市及買賣以及遵守香港結算之股份接納規定後， 供股股份（以未繳股款及繳足股款形式）將獲香港結算接納為合資格證券，可自該等供股股份（以未繳股款及 繳足股款形式）各自於聯交所開始買賣日期或香港結算釐定之有關其他日期起於中央結算系統內寄存、結 算及交收。聯交所參與者之間於任何交易日進行之交易須於其後第二個交易日在中央結算系統內進行交收。 在中央結算系統進行之一切活動均須依據不時生效之中央結算系統一般規則及中央結算系統運作程序規 則進行。

供股須待（其中包括）包銷協議成為無條件且包銷商並無根據包銷協議之條款（有關概要載於供股章程「終止 包銷協議」一節）終止包銷協議後方可作實。因此，供股可能或可能不會進行。

接納及付款手續

閣下如欲全數接納暫定配額，須不遲於二零二一年十一月十五日（星期一）下午四時正（或於惡劣天氣及╱ 或極端情況下根據下文「 惡劣天氣或極端情況對接納供股股份並繳付股款以及申請額外供股股份並繳付股 款之最後時限之影響 」一段所述之有關較後時間或日期），按本暫定配額通知書所印列之指示將本暫定配額 通知書整份連同表格甲之丙欄所示接納時應全數繳足之港元股款，送達過戶處卓佳證券登記有限公司，地 址為香港皇后大道東 183 號合和中心 54 樓。所有股款須以港元支付，並以香港持牌銀行賬戶開出的支票或 香港持牌銀行發出的銀行本票支付，以「 LINK-ASIA INTERNATIONAL MEDTECH GROUP LIMITED — PAL

–PAL-15–

ACCOUNT 」為收款人，並以「 只准入抬頭人賬戶 」劃線方式開出。有關付款將構成根據本暫定配額通知書及 供股章程之條款，並在本公司組織章程大綱及細則規限下接納暫定配額。本公司將不會發出股款收據。所 有與本暫定配額通知書有關的查詢應寄送至上述地址的過戶處。

務請注意，除非原承配人或任何有效承讓暫定配額之人士如上文所述不遲於二零二一年十一月十五日（星期一） 下午四時正（或於惡劣天氣及╱或極端情況下根據下文「 惡劣天氣或極端情況對接納供股股份並繳付股款以 及申請額外供股股份並繳付股款之最後時限之影響 」一段所述之有關較後時間或日期）將本暫定配額通知書 連同表格甲之丙欄所示之適當股款交回過戶處以作登記，否則本暫定配額通知書下之有關暫定配額及其項 下之一切權利及配額將被視為已遭拒絕及將予註銷，而有關供股股份將可供合資格股東以額外申請表格作 出申請。本公司毋須但可全權酌情將未有按照有關指示填妥之暫定配額通知書視作有效及對交回有關表格 或代表其交回有關表格之人士具有約束力。本公司可於較後階段要求相關申請人將未填妥之暫定配額通知 書填妥。

申請認購額外供股股份

合資格股東可以額外申請方式申請認購 (i) 最後接納時限前已暫定配發但未獲任何合資格股東接納或未繳股 款供股股份之承讓人另行認購之任何未繳股款供股股份；(ii) 據包銷協議之條文，暫定配發予本公司代名人 之任何尚未出售之除外股東權利；(iii) 匯集零碎供股股份所產生之任何供股股份；及 (iv) 縮減暫定配額通知 書股份（如有）及縮減額外申請表格股份（如有）。

額外供股股份僅可透過填妥及簽署額外申請表格申請認購。本公司將在與包銷商諮詢後參考所申請的額外 供股股份數目按比例將任何額外供股股份配發予作出申請之合資格股東。僅參考所申請之額外供股股份數 目但不會參考透過暫定配額通知書申請中包含之供股股份或合資格股東所持有之現有股份數目。倘合資格 股東及╱或未繳股款供股股份之承讓人未能根據暫定配額通知書承購之供股股份總數大於透過額外申請 表格申請之額外供股股份總數，本公司將向申請額外供股股份之每位合資格股東分配所申請之全部供股股份。 概不會優先處理用於補足所持碎股至完整買賣單位之申請。務請注意，交回額外申請表格並不保證合資格 股東將獲配發超出其暫定配額之任何供股股份。

合資格股東如欲申請認購其暫定配額以外之任何供股股份，則須填妥並簽署隨附供股章程之額外申請表格， 並於二零二一年十一月十五日（星期一）下午四時正（或於惡劣天氣及╱或極端情況下根據下文「 惡劣天氣或 極端情況對接納供股股份並繳付股款以及申請額外供股股份並繳付股款之最後時限之影響 」一段所述之有 關較後時間或日期），連同就所申請額外供股股份應付之獨立支票或銀行本票一併交回過戶處。所有股款 必須以港元繳付，並以香港持牌銀行賬戶開出的支票或香港持牌銀行發出的銀行本票支付，以「 LINK-ASIA INTERNATIONAL MEDTECH GROUP LIMITED[—] EAF ACCOUNT 」為收款人，並以「只准入抬頭人賬戶」劃線 方式開出。概不會就任何已收取股款發出收據。

縮減機制

根據包銷協議及委任，但受最高承諾規限，由於供股僅由包銷商按竭誠基準包銷，為避免無意引致強制性 全面收購要約責任及╱或違反公眾持股量規定，無論根據暫定配額通知書或額外申請表格或由未繳股款供 股股份之承讓人或由包銷商促使之認購人作出之全部供股股份申請，均將根據該等申請由本公司縮減至以 下水平之基準進行：(a) 不會引致申請人或與其一致行動人士一方之強制性全面收購要約責任；及╱或 (b) 不 會導致本公司一方違反公眾持股量規定。任何縮減暫定配額通知書股份或縮減額外申請表格股份之認購款 項將會退還予申請人，而其他合資格股東可透過額外申請表格認購該等縮減暫定配額通知書股份及縮減額 外申請表格股份。

–PAL-16–

此外，依照及╱或根據縮減機制，申請供股股份（無論根據暫定配額通知書或額外申請表格）須按照本公司 釐定之供股縮減機制縮減至不會引致任何強制性全面收購要約責任或不會違反公眾持股量規定之水平。供 股股份申請之有關縮減須根據以下原則按公平平等基準進行：(a) 額外申請表格項下申請應先於暫定配額通 知書項下申請縮減；及 (b) 倘由於一組而非個別股東之持股量超額而需縮減，則應參照受影響申請人於記錄 日期所持有股份數目按比例基準為受影響組別之成員分配額外申請表格及暫定配額通知書項下申請份額， 但為避免任何疑問，任何或任何此類後續分配亦應縮減。

轉讓

閣下如欲轉讓 閣下根據本暫定配額通知書獲暫定配發之供股股份之全部認購權，必須填妥及簽署「轉讓 及提名表格」（表格乙），並將本暫定配額通知書送交承讓權利之人士或經手轉讓權利之人士。其後，承讓人 須填妥及簽署「登記申請表格」（表格丙），並須不遲於二零二一年十一月十五日（星期一）下午四時正（或於惡 劣天氣及╱或極端情況下根據下文「 惡劣天氣或極端情況對接納供股股份並繳付股款以及申請額外供股股 份並繳付股款之最後時限之影響 」一段所述之有關較後時間或日期）將本暫定配額通知書整份連同表格甲內 之丙欄所示接納時應繳付之全部股款送達過戶處卓佳證券登記有限公司，地址為香港皇后大道東 183 號合 和中心 54 樓。

分拆

閣下如僅欲接納部分暫定配額，或轉讓 閣下根據本暫定配額通知書獲暫定配發之供股股份之部分認購 權，或向超過一名人士轉讓 閣下之部分或全部權利，則須不遲於二零二一年十一月五日（星期五）下午四 時三十分將原暫定配額通知書交回及送達過戶處卓佳證券登記有限公司（地址為香港皇后大道東 183 號合和 中心 54 樓）予以註銷，過戶處將會註銷原暫定配額通知書並按所需數目發出新暫定配額通知書。新暫定配額 通知書將可於 閣下交回原暫定配額通知書後第二個營業日上午九時正後於上文所載過戶處之地址領取。 務請注意， 閣下轉讓認購相關供股股份的權利予承讓人以及承讓人接納有關權利須繳納香港從價印花稅。

惡劣天氣或極端情況對接納供股股份並繳付股款以及申請額外供股股份並繳付股款之最後時限 之影響

每當包銷協議條文所載的供股預期時間表的任何部分因颱風、黑色暴雨警告或極端情況而被迫中斷時，本 公司應妥為知會股東相應應急安排，應急安排應包括未能如期發生之最後接納時限：

• (a) 倘八號或以上熱帶氣旋警告信號、黑色暴雨警告及╱或極端情況於最後接納時限按計劃初步到期之日 的本地時間中午十二時正前的任何時間在香港生效但於中午十二時正後不再生效，則最後接納時限將 延長至該營業日下午五時正；或

• (b) 倘八號或以上熱帶氣旋警告信號、黑色暴雨警告及╱或極端情況於最後接納時限按計劃初步到期之日 的本地時間中午十二時正至下午四時正期間的任何時間在香港生效，則最後接納時限將延長至於上午 九時正至下午四時正期間任何時間該等警告均未在香港生效的下一營業日的下午四時正。

倘最後接納時限並非在二零二一年十一月十五日（星期一）下午四時正或之前發生，則本文件所述之日期可 能受到影響。本公司將就供股之預期時間表之任何變動在實際可行的情況下盡快以公告之方式通知股東。

–PAL-17–

零碎配額

在任何情況下，零碎供股股份將不會暫定配發予任何合資格股東，且本公司將不會接納任何零碎供股股份 的申請。零碎配額將向下約整至最接近之供股股份整數。誠如上文「 申請認購額外供股股份 」一節所述，匯 集零碎供股股份所產生之任何供股股份將可供合資格股東相應作出額外申請。倘合資格股東並無作出額外 申請，匯集零碎供股股份所產生之該等供股股份可能會亦可能不會由包銷商承購。

買賣股份及未繳股款供股股份之風險警告

務請注意，股份已於二零二一年十月二十一日（星期四）開始按除權基準買賣。未繳股款供股股份將於二 零二一年十一月三日（星期三）至二零二一年十一月十日（星期三）（首尾兩天包括在內）開始買賣。倘於二零 二一年十一月十六日（星期二）下午四時正（或本公司與包銷商可能書面協定日期的有關較後時間或日期）或 之前，任何一項供股先決條件未獲達成或豁免（如適用）或倘包銷商終止包銷協議之權利，則供股將不會進行。

直至供股之所有先決條件獲達成或獲豁免（如適用）當日（及包銷商終止包銷協議之權利終止當日）前買賣股 份及╱或未繳股款供股股份之任何股東或其他人士，將因而承擔供股可能不會成為無條件或可能不會進行 之風險。

本公司股東及潛在投資者於買賣股份及╱或未繳股款供股股份時務請審慎行事。任何人士（包括本公司股 東及潛在投資者）如對本身之狀況或將予採取之行動有任何疑問，務請諮詢本身之專業顧問。

支票及銀行本票

所有支票或銀行本票將於收訖後過戶，而有關款項賺取的所有利息將撥歸本公司所有。在不影響本公司與 此有關的其他權利的情況下，本公司保留拒絕受理任何隨附支票及╱或銀行本票於首次過戶時未獲兌現的 供股股份申請的權利，而在該情況下，該暫定配額及其項下一切權利將被視作已遭拒絕及將予註銷。 閣 下申請認購供股股份時須繳付準確股款金額，以及未繳足股款申請將不獲受理。填妥本暫定配額通知書 並連同繳付供股股份之股款支票或銀行本票一併交回（不論由合資格股東或任何指定承讓人交回），即表 示 閣下保證支票或銀行本票可於首次過戶時兌現。

供股股份的股票及供股的退款支票

待供股的先決條件達成後，預期繳足股款供股股份的股票將於二零二一年十一月二十三日（星期二）或之前 以普通郵寄方式寄發予有權接收股票之股東的登記地址，郵誤風險概由彼等自行承擔。倘包銷協議終止或 並未成為無條件，則退款支票將於二零二一年十一月二十三日（星期二）或之前以普通郵寄方式寄發予相關 股東之登記地址，郵誤風險概由彼等自行承擔。有關全部或部分不獲接納的額外供股股份申請的退款支票（如 有），預期將於二零二一年十一月二十三日（星期二）或之前以普通郵寄方式寄發予該等申請人的登記地址， 郵誤風險概由彼等自行承擔。每名股東將就所有獲配發之股份收取一張股票。

終止包銷協議

倘於最後終止時限前：

• (1) 包銷商全權認為，供股的成功進行將受到下列事件的重大不利影響：

• (a) 頒佈任何新法例或法規或現時之法例或法規（或其有關司法詮釋）出現任何變動或出現任何其他事 件（不論其性質），而包銷商全權認為令本集團的整體業務或財務或經營狀況或前景受到重大不利 影響，或對供股造成重大不利影響；或

–PAL-18–

• (b) 任何地方、國家或國際間發生有關政治、軍事、金融、經濟或其他性質（無論是否與任何上述者屬 同一類別）的事件或變動（無論是否於本表格日期之前及╱或之後發生或持續發生的一連串事件或 變動其中一部分），或任何地方、國家或國際間爆發敵對衝突或衝突升級或武裝衝突，或發生可影 響當地證券市場的事件，而包銷商全權認為可能令本集團整體業務或財政或經營狀況或前景受到 重大不利影響或令供股的成功進行受到重大不利影響，或基於其他理由導致不適宜或不應進行供股； 或

• (2) 市場狀況出現任何不利變動（包括但不限於財政或貨幣政策或外匯或貨幣市場的任何變動、證券買賣 被暫停或受到重大限制），而包銷商全權認為可能對供股的成功進行造成重大不利影響，或基於其他理 由導致不適宜或不應進行供股；或

• (3) 本公司或本集團任何成員公司的情況出現任何變動，而包銷商全權認為將令本公司的前景受到不利影響， 包括（但不限於上述一般性情況）本集團任何成員公司被提出清盤呈請或通過決議案清算或清盤或出現 類似事件或本集團任何重大資產被損毀；或

• (4) 任何不可抗力事件，包括（但不限於其一般性情況）任何天災、戰爭、暴動、動亂、騷亂或動盪、火災、水 災、爆炸、疫症、流行病、恐怖活動、罷工或停工，而包銷商全權認為將令本集團整體業務或財政或經 營狀況或前景受到重大不利影響；或

• (5) 包銷商全權認為出現有關本集團整體業務或財務或經營狀況或前景的任何其他重大不利變動（無論是 否與上述任何一項屬同一類別）；或

• (6) 任何事件倘於緊接章程寄發日期前出現或發現，惟並無於章程文件內披露，而包銷商全權認為將對供 股而言構成重大遺漏者；或

• (7) 聯交所二十 (20) 個連續營業日以上全面暫停證券買賣或暫停本公司證券的買賣（因或與包銷協議及╱或 供股相關者及涉及審批有關包銷協議及╱或供股的公告或其他事宜而暫停買賣者則除外）；或

• (8) 章程文件刊發時載有於本表格日期之前未經本公司公開宣佈或刊發的資料（不論是關於本集團的業務 前景或狀況或關於本集團遵守任何法例或上市規則或任何適用規例），而包銷商可能全權認為在供股 完成後對本集團整體而言屬重大，並很可能對成功進行供股造成重大不利影響，

包銷商有權於最後終止時限前向本公司發出書面通知終止包銷協議。

倘包銷商終止包銷協議，則將不會進行供股。倘包銷商終止包銷協議，本公司將另行作出公告。

派發本暫定配額通知書及其他章程文件

本暫定配額通知書僅向合資格股東寄發。章程文件將不會根據香港以外任何司法權區之適用證券法例進行 登記或存檔。本公司並無採取任何行動，以批准在香港以外任何地區提呈發售供股股份或派發章程文件。

因此，倘任何人士在香港以外任何地區接獲任何章程文件之文本，除非在該地區可合法提呈有關要約或邀 請而毋須遵守其任何登記或其他法律或監管規定，否則不可視作提呈申請供股股份之要約或邀請。

–PAL-19–

於香港以外地區有意申請供股股份之合資格股東，須於取得認購供股股份之任何權利前自行遵守所有相關 地區之法例及規例（包括取得任何政府或其他同意及就此繳付任何有關地區規定須繳付之稅項及徵費）。任 何人士就供股股份之接納或申請將被視為構成有關人士向本公司之聲明及保證，表示有關當地法律及規定 已獲全面遵守。 閣下如對自身的情況有任何疑問，應諮詢 閣下之專業顧問。倘本公司相信接納額外供股 股份的任何申請將會觸犯任何司法權區的適用證券或其他法例或規例，則本公司保留權利拒絕接納有關申 請。為免生疑問，香港結算或香港中央結算（代理人）有限公司概不作出任何上述聲明及保證或受其規限。

一般事項

本暫定配額通知書連同（如相關）宣稱由獲發本暫定配額通知書人士所簽署之「轉讓及提名表格」（表格乙）一 經交回，即表示交回之人士或各方就處理本暫定配額通知書及收取分拆配額通知書及╱或供股股份之股票 擁有最終所有權憑證。

個人資料收集[—] 暫定配額通知書

閣下填妥、簽署及交回本暫定配額通知書隨附表格，即表示同意向本公司、過戶處及╱或彼等各自之顧問 及代理披露個人資料及彼等所需有關 閣下或 閣下為其利益而申請供股股份的人士之任何資料。香港法 例第 486 章個人資料（私隱）條例（「 該條例 」）賦予證券持有人權利向本公司或過戶處確定是否持有彼等之個人 資料、索取有關資料之文本及更正任何不準確之資料。根據該條例，本公司及過戶處有權就處理任何查閱 資料之要求收取合理費用。有關查閱資料或更正資料或有關政策及慣例以及持有資料種類之資料的所有要求， 應寄往(i)本公司於香港的主要營業地點（地址為香港九龍尖沙咀海港城港威大廈第6座35樓3501及3513–14室， 或根據適用法律不時作出通知之地點）並以本公司的公司秘書為收件人，或 (ii)（視情況而定）過戶處（上文所 示地址）並以私隱條例事務主任為收件人。

此 致

列位合資格股東 台照

代表 環亞國際醫療科技集團有限公司 主席兼執行董事 林代聯 謹啟

二零二一年十一月一日

–PAL-20–